CompletedPhase 1NCT04359823
DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone
Studying Disseminated superficial actinic porokeratosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of South Carolina
- Principal Investigator
- Dirk Elston, MD, MDMedical University of South Carolina
- Intervention
- Lovastatin 2%, 2% Cholesterol Cream(drug)
- Enrollment
- 31 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2021
Study locations (1)
- Medical University of South Carolina, Charleston, South Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04359823 on ClinicalTrials.gov